In search of useful methods for measuring health and economic consequences of antimicrobial resistance.

[1]  E. Lingaas,et al.  Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. V. van Hal,et al.  Predictors of Mortality in Staphylococcus aureus Bacteremia , 2012, Clinical Microbiology Reviews.

[3]  Peter Davey,et al.  Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. , 2011, The Journal of antimicrobial chemotherapy.

[4]  P. Davey,et al.  Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. , 2011, The Journal of antimicrobial chemotherapy.

[5]  P. Davey,et al.  Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-Resistant Staphylococcus aureus Bloodstream Infections , 2011, Antimicrobial Agents and Chemotherapy.

[6]  J. Hurley.  Risk of death from methicillin‐resistant Staphylococcus aureus bacteraemia: a meta‐analysis , 2002, The Medical journal of Australia.

[7]  K. Mertens,et al.  Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. , 2011, The Lancet. Infectious diseases.

[8]  S. Cosgrove,et al.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.